News & Publications
EORTC and ESTRO announce E²-RADIatE platform’s first site activation for Oligometastatic Disease
EORTC and ESTRO announce E²-RADIatE platform’s first site activation for […]
EORTC and ESTRO announce E²-RADIatE platform’s first site activation for […]